Clinical Trial Update: A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates docetaxel for injection (albumin-bound) is being studied in gastric cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Docetaxel for Injection (Albumin Bound) (docetaxel (albumin-bound formulation))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: RECRUITING